论文部分内容阅读
目前“难治性心力衰竭”的住院死亡率颇高,从不同方面探讨本病的治疗实属必要。除洋地黄类药物外,利尿剂和血管扩张剂的使用也可提高心衰的好转率;但目前对其发病机理的认识和治疗措施大多还停留在一般水平上。本刊这次发表的3篇文章,涉及心室舒张功能障碍及当前药物的进展、老年人难治性充血性心力衰竭及慢性肾炎心力衰竭与心肌梗塞等方面。我们认为,正确的药物配伍、新药的临床应用等很多问题值得深入讨论。希望通过这次讨论,能够引出更多更深入的包括部分创伤性治疗的文章;也希望临床学家们能协同研究,进一步提高心力衰竭的好转率,减少死亡率,为广大患者造福。
At present, “refractory heart failure,” the hospital mortality is high, from different aspects to explore the treatment of the disease is necessary. In addition to digitalis drugs, the use of diuretics and vasodilators can also improve the rate of improvement of heart failure; but the current understanding of the pathogenesis and treatment are still at a general level. Articles published in this article 3 articles related to ventricular diastolic dysfunction and the current progress of drugs, refractory congestive heart failure in elderly patients and chronic nephritis heart failure and myocardial infarction and so on. In our opinion, many issues such as correct drug compatibility and the clinical application of new drugs deserve further discussion. I hope this discussion can lead to more and more articles including some traumatic treatments. I also hope that clinicians can work together to further improve the rate of improvement of heart failure and reduce the mortality rate for the benefit of the majority of patients.